Back to top
Lupride Depot 11.25 mg Injection
Lupride Depot 11.25 mg Injection

Lupride Depot 11.25 mg Injection

Lupride Depot 11.25 mg Injection Specification

  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Salt Composition
  • Leuprorelin Acetate
  • Drug Type
  • Injection
  • Ingredients
  • Leuprorelin Acetate
  • Physical Form
  • Liquid
  • Function
  • Regulates hormone levels and is used in the treatment of hormone-responsive cancers (e.g. prostate cancer breast cancer) and disorders such as endometriosis.
  • Recommended For
  • Hormonal therapy for cancers and related medical conditions like endometriosis.
  • Dosage
  • 11.25 mg per dose
  • Dosage Guidelines
  • Administered as directed by the physician typically on a monthly or three-monthly basis as prescribed.
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store in a refrigerator (2-8°C). Do not freeze. Protect from light.
 
 

About Lupride Depot 11.25 mg Injection



Lupride Depot 11.25 mg Injection is a synthetic medicine containing Leuprorelin Acetate. It is packed in a box with 1 vial, suitable for adults and stored in a refrigerator between 2-8C. This injection is specifically recommended for hormonal therapy in cancers and medical conditions like endometriosis. The liquid form of Lupride Depot 11.25 mg functions by regulating hormone levels and is commonly used in treating hormone-responsive cancers such as prostate cancer, breast cancer, and disorders like endometriosis. Each dose contains 11.25 mg of Leuprorelin Acetate, to be administered as prescribed typically on a monthly or three-monthly basis.

FAQs of Lupride Depot 11.25 mg Injection:


Q: What is Lupride Depot 11.25 mg Injection used for?

A: Lupride Depot 11.25 mg Injection is primarily used for hormonal therapy in cancers and medical conditions like endometriosis.

Q: How should Lupride Depot 11.25 mg Injection be stored?

A: It should be stored in a refrigerator between 2-8C, avoiding freezing and exposure to light.

Q: What is the dosage of Lupride Depot 11.25 mg Injection?

A: Each dose contains 11.25 mg of Leuprorelin Acetate, to be administered as directed by the physician, typically on a monthly or three-monthly basis.

Q: What are the main ingredients of Lupride Depot 11.25 mg Injection?

A: The main ingredient is Leuprorelin Acetate.

Q: Who can use Lupride Depot 11.25 mg Injection?

A: Lupride Depot 11.25 mg Injection is suitable for adults and should only be used as directed by a healthcare professional.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Myzotem 250 mg Capsule

Myzotem 250 mg Capsule

Dosage : 250 mg per capsule

Ingredients : Contains Myzotem 250 mg

Salt Composition : Myzotem (250 mg)

Drug Type : Other, Capsule

Dosage Guidelines : As directed by the physician; typically consumed with water

Recommended For : Patients requiring Myzotembased treatment

Anaridex 1 mg Tablet

Anaridex 1 mg Tablet

Dosage : 1 tablet daily

Ingredients : Anastrozole 1 mg

Salt Composition : Anastrozole

Drug Type : Other, Pharmaceutical

Dosage Guidelines : Take as directed by a healthcare professional preferably at the same time each day with or without food

Recommended For : Postmenopausal women with hormone receptorpositive breast cancer

Hertraz 150 mg Injection

Hertraz 150 mg Injection

Dosage : 150 mg vial

Ingredients : Trastuzumab 150 mg

Salt Composition : Trastuzumab

Drug Type : Other, Anticancer

Dosage Guidelines : Administered under the supervision of a healthcare professional

Recommended For : HER2positive breast cancer patients

Geffy 250 mg Tablet

Geffy 250 mg Tablet

Dosage : 250 mg per day or as directed by the physician

Ingredients : Gefitinib 250 mg

Salt Composition : Gefitinib

Drug Type : Other, Tablet

Dosage Guidelines : Should be taken orally with water with or without food; follow the doctors instructions

Recommended For : Patients diagnosed with nonsmall cell lung cancer